Breaks Categories: News

MondayOct 11, 2021 10:49 am

NetworkNewsBreaks – DeFi Technologies Inc. (NEO: DEFI) (GR: RMJ.F) (OTC: DEFTF) at Center of Syndicated Broadcast

DeFi Technologies (NEO: DEFI) (GR: RMJ.F) (OTC: DEFTF), a digital asset investment firm bridging the gap between traditional capital markets and decentralized finance, is a featured participant in a NetworkNewsAudio syndicated broadcast. The broadcast discusses the expansion of the company and its management team as DEFTF focuses on growth in international markets. According to the announcement, DeFi Technologies executive chair Russell Starr has been named CEO. In addition, the company has announced that Diana Biggs, formerly the CEO of Valour Inc., will become DEFTF chief strategy officer and Johan Wattenstrom, Valour cofounder and director, will serve as COO. During this year,…

Continue Reading

MondayOct 11, 2021 9:55 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Discusses Berubicin’s Impressive Potential in Syndicated Broadcast

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system (“CNS”), today announced that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. According to the update, the audio press release covers CNS Pharmaceuticals’ recent announcement of dosing of the first patients in its Berubicin clinical development program for the treatment of recurrent glioblastoma multiforme (“GBM”), one of the most aggressive types…

Continue Reading

FridayOct 08, 2021 11:22 am

NetworkNewsBreaks – BBQ Holdings, Inc. (NASDAQ: BBQ) Featured in Research Note from Sidoti

Corporate Update BBQ Holdings (NASDAQ: BBQ) was featured in a company-sponsored research note published by Sidoti & Company, LLC. The headline of the note reads, “BBQ’s Acquisition of Tahoe Joe’s Adds Five Steakhouses and Compelling IP; We Continue To Forecast Higher Franchisee Royalties Starting 3Q:21; Maintain $19 Target, Moderate Risk Rating.” Click here to access the full report About BBQ Holdings, Inc. BBQ Holdings, Inc. is a national restaurant company engaged in the ownership and operation of casual and fast dining restaurants. As of September 20, 2021, BBQ Holdings had six brands with 296 locations in three countries including 84 Company…

Continue Reading

ThursdayOct 07, 2021 2:32 pm

NetworkNewsBreaks – Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) Announces Entry into Strategic LOI

Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) today announced its entry into a letter of intent (“LOI”) for the formation of a commercial relationship with Kingston Cannabis Inc. (“KCI”), a Health Canada licensed producer, to launch its cannabis-infused beverages through a co-packing arrangement with KCI. Under the arrangement, KCI’s affiliate, Kingston Aluminum Technologies Inc. (“KAT”) will provide custom designed aluminum packaging for Sproutly’s products. In addition, KCI and Sproutly will collaborate on the consumer evaluation of Sproutly’s formulations made using ingredients produced by the proprietary APP cannabis processing technology. “This relationship will allow us to launch our beverages made…

Continue Reading

ThursdayOct 07, 2021 2:12 pm

NetworkNewsBreaks – Clearmind Medicine Inc. (CSE: CMND) Engages Clinipace in Pursuit of FDA Approval for Therapeutics

Clearmind Medicine (CSE: CMND), a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and undertreated health problems, today announced a strategic partnership. Clearmind has engaged Clinipace Incorporated, a full-service contract research organization (“CRO”), to advise the company in its pursuit of Food and Drug Administration (“FDA”) approval for its therapeutics. “Moving any drug through the FDA approval process requires deep expertise and meticulous attention to detail; this is particularly true for psychedelics,” said Adi Zuloff-Shani, PhD., CEO of Clearmind. “We chose Clinipace as our CRO as they have facilitated dozens of…

Continue Reading

ThursdayOct 07, 2021 1:50 pm

NetworkNewsBreaks – DSG Global Inc. (DSGT), Imperium Motor Add INDI EV Crossover Sedan to LA Auto Show Lineup

DSG Global (OTCQB: DSGT) today announced that its electric vehicle division, Imperium Motor Company, will be showcasing the new INDI EV fully electric crossover sedan. “We are pleased to announce the inclusion of the new INDI crossover sedan to our lineup at the Los Angeles International Auto Show. This will be the first major auto show event for this highly anticipated fully electric vehicle. This extremely well-equipped all-new vehicle fits nicely into our Imperium product lineup along with the Imperium SEV, TradePro Vans and other EV models,” said Rick Curtis, CEO of Imperium Motor Corp. “INDI is based in Los Angeles…

Continue Reading

ThursdayOct 07, 2021 1:15 pm

NetworkNewsBreaks – PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) Applies to Uplist to the Toronto Stock Exchange

PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced that it has applied to list (“uplist”) its common shares on the Toronto Stock Exchange (“TSX”) with the view of increasing access to capital markets. According to the update, the uplisting is subject to the approval of the TSX in accordance with its original listing requirements. The TSX has not conditionally approved PlantX’s application and there is no assurance that it will approve the listing application or that PlantX will complete the uplisting as proposed. “Uplisting our shares to the TSX will mark a valuable milestone that will highlight PlantX’s impact…

Continue Reading

ThursdayOct 07, 2021 12:49 pm

NetworkNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) to Present at KCSA Psychedelics Virtual Investor Conference

Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) (“MINDCURE”), a leader in advanced proprietary technology and research for psychedelics, today announced that its president and CEO Kelsey Ramsden will present virtually at the KCSA Psychedelics Investor Conference, which will be held Oct. 13-14, 2021, at VirtualInvestorConferences.com. Ramsden’s presentation is scheduled to begin at 12 p.m. ET on Oct. 13, 2021. The live, interactive online event is designed to enable investors to ask presenting companies questions in real-time. Interested parties should visit https://nnw.fm/80oP3 to register for and access the event. It is recommended that investors pre-register and run the online system check to expedite…

Continue Reading

ThursdayOct 07, 2021 12:31 pm

NetworkNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Announces Collaboration with University of Wisconsin Researchers to Evaluate TRP-8803

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, this morning announced a collaboration to support clinical pharmacology studies for Tryp’s proprietary drug product TRP-8803. Dr. Paul Hutson, Professor of the Pharmacy Practice Division at the University of Wisconsin-Madison School of Pharmacy and Dr. Christopher Nicholas, Assistant Professor at the University of Wisconsin School of Medicine, will serve as investigators on the clinical pharmacology studies to assess the pharmacokinetics and safety of TRP-8803 in healthy, volunteer patients. The completion of the studies is anticipated to deliver additional regulatory support…

Continue Reading

ThursdayOct 07, 2021 11:54 am

NetworkNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Achievement of Adelia Milestones

Cybin (NYSE American: CYBN) (NEO: CYBN), a biotechnology company focused on psychedelic pharmaceutical therapies, has announced that Adelia Therapeutics Inc., a wholly-controlled subsidiary of Cybin, has achieved the milestones identified as “Year 2 Q1 (i)-(iii).” According to the update, the milestones were contemplated by the terms of a contribution agreement dated Dec. 4, 2020, among Cybin, Cybin Corp., Cybin US Holdings Inc. (the “acquiror”), a wholly controlled subsidiary of Cybin, and all previous shareholders of Adelia. Per the terms of the agreement, Class B common shares in the capital of the acquiror shall be issued to Adelia shareholders, in satisfaction…

Continue Reading